<DOC>
	<DOCNO>NCT00800865</DOCNO>
	<brief_summary>A study evaluate biomarkers cancer ( context-specific sensitizer ) skin participant already receive cytotoxic therapy . Additional blood urine sample collect phosphorylated Histone 2AX ( Î³H2AX ) renal toxicity biomarker test , respectively .</brief_summary>
	<brief_title>A Study Evaluate Biomarkers Patients With Solid Tumors ( 0000-097 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<criteria>Participant solid tumor treat one follow treatment : Gemcitabine monotherapy Cisplatin monotherapy Carboplatin monotherapy Gemcitabine cisplatin combination therapy Gemcitabine erlotinib combination therapy Gemcitabine carboplatin combination therapy Cisplatin vinorelbine combination therapy Cisplatin pemetrexed combination therapy Carboplatin vinorelbine combination therapy Carboplatin pemetrexed combination therapy Participant recent cancer treatment include chemotherapy radiation Participant investigational study within last 30 day Participant history drug alcohol abuse Participant Human Immunodeficiency Virus ( HIV ) positive history Hepatitis B C</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>